Advanced Biotechnologies Inc - Announcements

ABI Releases Toxoplasma gondii strain RH Purified Tachyzoites Lysate to Assist Investigators In T. gondii Research

New product useful for determining the immune response against Toxoplasma gondii, to assist investigators working on improving the methods used to detect T. gondii infection.  ...more »

ABI Releases 2009 Influenza A (H1N1) Purified Virus Products to Assist Investigators in Studying New Pandemic Influenza Strains

ABI’s two new 2009 Influenza A purified virus products are suitable for a variety of assays and in characterization to meet investigators’ demand for purified virus for ongoing research on 2009 Influenza A (H1N1) original isolates.  ...more »

Advanced Biotechnologies Inc Releases Dengue-1 Purified Viral Lysate to Diagnose Infections; Useful Tool to Combat Epidemics

ABI’s Dengue-1 Purified Viral Lysate allows investigators to detect primary and secondary infections of Dengue-1 by immunoassays.  Epidemics of Dengue fever spread across the world while vaccines are still under development.

 ...more »

Advanced Biotechnologies Inc’s HHV-7 H7-4 Quantitated DNA Control Works With Investigators’ Multiplex PCR Detection Methods

ABI’s HHV-7H7-4 Quantitated DNA Control allows researchers to detect and quantify HHV-7, which causes Roseola and fatal transplant complications.  This control can also be used in a PCR method that detects HHV-6 and HHV-7 at the same time.

 ...more »

Advanced Biotechnologies Inc’s Human A/B Serum Effective In Monocyte Differentiation, Many Other Applications

ABI’s new Human A/B Serum works in conjunction with the company’s Elutriated Human Adult Monocytes, and has a wide variety of additional applications.  ...more »

New Product Release: Human Influenza A/2/Japan/305/57 (H2N2) Purified Whole Virus, UV-Inactivated

Human Influenza A/2/Japan/305/57 (H2N2) Purified Whole Virus, UV-Inactivated Cat. No. 10-276-000 was completely inactivated by ultraviolet light irradiation. The inactivation was validated by cell culture based assay and had no effect on the hemagglutinin titer by hemagglutination assay (HA) and retained viral morphology by TEM. The inactivated, purifed human influenza A virus will be useful for any H2N2 subtype-specific protein-based testing.

 ...more »

New Product Release: Cytomegalovirus (CMV) AD169 Purified Virus, B-PL Inactivated

Columbia, MD - May 2009 Cytomegalovirus (CMV) AD169, Purified Whole Virus Cat. No. 10-275-500 was inactivated by treatment with Beta-propiolactone (B-PL). B-PL is a DNA alkylating agent that has been shown to be effective in the inactivation of a virus. It chemically modifies viral DNA without affecting the immunogenicity or protein structure. After treatment with B-PL, infectious CMV was completely inactivated as validated by cell culture based assay, but retained viral morphology (by TEM). 

 ...more »

ADVANCED Biotechnologies, Inc. to attend the 23rd Annual Clinical Virology Symposium (CVS) at Booth 413

COLUMBIA MD – March 2009 – Advanced Biotechnologies Incorporated is a privately held company specializing in development, manufacture, and supply of critical products and services for the research and monitoring of infectious diseases. Advanced Biotechnologies Inc. has proven to be a valuable partner for 27 years to Pharmaceutical, Biotechnology, Diagnostic, and Laboratory companies by using unparalleled manufacturing techniques to obtain optimal results.
 ...more »

New Product Release: Rubella Purified Virus, strain HPV77, UV-Inactivated

10-270-000: Electron Microscopy photograph of Purified Rubella Virus (ABI): 150,000X
Rubella virus, strain HPV77, was propagated in Vero cells and was sucrose gradient purified as a whole virus particle antigen. This highly infectious virus preparation was then UV-inactivated to produce antigen for ELISA and other assay formats. The quality control data indicates that antigen is specifically immunoreactive by ELISA after UV-inactivation, using Rubella specific monoclonal antibody. This antigen also performed well with negative and positive Rubella specific human sera panels for IgG and IgM by ELISA.
 ...more »
Syndicate content